Selection of cytotoxic T-cell precursors specific for minor histocompatibility determinants. I. Negative selection across H-2 barriers induced with disrupted cells but not with glutaraldehyde- treated cells: evidence for antigen processing by unknown
SELECTION  OF  CYTOTOXIC  T-CELL  PRECURSORS 
SPECIFIC  FOR  MINOR 
HISTOCOMPATIBILITY  DETERMINANTS 
I.  Negative Selection Across H-2 Barriers Induced with 
Disrupted Cells but Not with Glutaraldehyde- 
treated Cells:  Evidence for Antigen  Processing* 
BY R. KORNGOLD AND J. SPRENT 
From the Division of Research Immunology, Department of Pathology, School of Medicine,  University of 
Pennsylvania, Philadelphia,  Pennsylvania 19104," and The  Wistar Institute,  Philadelphia,  Pennsylvania 
19104 
It is well accepted that cytotoxic lymphocytes specific for viruses (1), haptens  (2), 
and  minor  histocompatibility  antigens  (HA) 1 (3,  4)  recognize  antigen  in  an  H-2- 
restricted fashion during the effector phase. Precisely how the precursors of these cells 
respond to antigen during the induction phase, however, is poorly understood. In the 
case of skin graft rejection (5-9) and delayed-type hypersensitivity (10)  to minor HA, 
mice can be primed with antigen presented on H-2-incompatible cells. Likewise, H-2 
heterozygous mice primed  with  minor  HA on  cells  of one  parental  strain  develop 
cytolytic activity for target  cells of both  parental  haplotyes  (1 1,  12).  This effect of 
cross-priming suggests either that certain aspects of the response to minor HA are not 
H-2 restricted or, conversely, that  the antigens  are processed by host cells and then 
presented in association with host H-2 determinants in a restricted fashion (12). 
To attempt to clarify this question and, in particular,  to gain information on the 
early stages of the cytotoxic T-cell  response,  we have studied  the  requirements  for 
inducing negative and positive selection to minor HA in vivo. Previous work with this 
selection  model  has established  that  within  1 d  of T-cell confrontation  with  such 
antigens  as heterologous erythrocytes  (13,  14)  or foreign  H-2 determinants  (13-16) 
the responding T  cells leave the circulation  (undergo negative selection) and become 
selectively sequestered  in the lymphoid tissues.  Here, the cells proliferate extensively 
before reentering the circulation in expanded numbers after 2-3 d  (positive selection). 
In the case ofT-helper cells for heterologous erythrocytes, T-cell selection appears not 
to involve a response to free antigen but rather to antigen that has been processed by 
macrophages or related cells (17).  The present studies suggest that, at least in certain 
situations,  a  similar requirement  for antigen  processing applies  to  the  induction  of 
cytotoxic lymphocytes specific for minor HA. 
* Supported by grants AI-10961, AI-15393, and CA-15822 from the U. S. Public Health Service. 
i Abbreviations used in this paper." CML, cell-mediated lympholysis;  HA, histocompatibility  antigen  (s); LU, 
lytic units; MR, maximum release of radioactivity; SR, spontaneous release; TDL, thoracic duct lympho- 
cytes. 
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Materials and Methods 
Mice.  CBA/J(H-2k),  BIO.BR/SgSn(H-2k),  C57BL/lOJ(H-2b)(BlO),  BIO.D2(H-2 d) 
BIO.A(H-2a),  and  (BALB/c[H-2  ]  X  A/J[H-2  ])F1 mice were  obtained from  The Jackson 
Laboratory, Bar  Harbor,  Maine. B10.K(H-2k),  B I04.AQR(H-2  yl)  (fourth backcross genera- 
tion), B 10.T(6R) (H-2~2), and B 10.S(9R) (H-2  t4) mice were a gift from W. L. Elkins, University 
of Pennsylvania (Philadelphia, Pa.). B 10.OL(H-2  °a) mice were provided by C. David, Mayo 
Clinic, Rochester, Minn. B IO.Q(H-2 q) mice were given by D. Gasser, University  of Pennsylvania 
(Philadelphia, Pa.),  and BI0.A(4R)(H-2  h4)  and  B10.HTT(H-2  t3)  mice were donated by P. 
Doherty, Wistar Institute, Philadelphia, Pa. (B 10.A X B 10.OL)Fx mice were bred in our colony. 
Media.  RPMI-1640 (Microbiological Associates, Walkersville, Md.) supplemented with 10% 
fetal  calf serum,  10  -5  M  2-mercaptoethanol,  and  40  /xg/ml  Garamycin  (Schering  Corp., 
Kenilworth, N.J.) was used in all experiments. 
Preparation of Cells.  Spleen cells were obtained by shearing the organs with a tissue grinder 
(Pyrex, Arthur H. Thomas Co., Philadelphia, Pa.) in cold medium. Clumps were removed by 
passage  over cotton filters,  and the suspended cells were washed twice by centrifugation. Cell 
viability was assessed by dye exclusion. 
Injection.  All cell  suspensions were  given intravenously in volumes of  I  ml unless stated 
otherwise. 
Selection to minor HA.  The technique used was essentially similar to that described previously 
for inducing  selection to H-2 determinants (16). In brief, CBA mice were injected intravenously 
with large doses of spleen cells taken from normal syngeneic or minor HA-different allogeneic 
mice. To study negative selection, thoracic duct cannulae were inserted in the recipients ~ 18 h 
later and thoracic duct lymphocytes (TDL) were collected under sterile conditions between 22 
and 40 h  after spleen cell  injection; other groups of mice were used to provide spleen and 
lymph node cells,  these  cells being harvested at 40 h  after spleen-cell injection. For positive 
selection, the injected mice were cannulated at day 4 or 5 postinjection and TDL were collected 
overnight. 
Priming to Minor HA In  Vivo.  All host mice used for selection were immunized intraperito- 
neally 3-6 wk before with 2 ×  10  7 viable BI0.BR spleen cells. 
Irradiation of Cells.  Cells were exposed to 2,000 rad of 137Cs y-irradiation at a  dose of 102 
rad/min and then incubated at 37°C for 3-4"h (16). The cells were then washed twice before 
injection. The viability of the injected cells was 70-80%. 
Disruption of Cells.  Spleen cells were resuspended to 2  ×  108/mt  in round-bottom plastic 
tubes and subjected to high frequency sonication (Branson Sonifier [Branson Sonic Power Co., 
Danbury, Conn.], 6 A, 30 s) at 4°C. No intact cells remained when the sonicates were viewed 
microscopically. 
Treatment of Cells with Glutaraldehyde.  Spleen cells were first resuspended in low ionic strength 
buffer and passaged  over cotton filters  to remove dead cells  (18). In a  modification of the 
method of Bubbers and Henney (19), cells were then washed once and resuspended at room 
temperature in 10 ml 0.002% glutaraldehyde (Electron Microscopy Sciences, Fort Washington, 
Pa.)  diluted in buffered saline (pH 7.1). Fixation was stopped after 30 s by addition of 30 ml 
0.15 M  glyeine (diluted in buffered saline). The cells were then washed twice in cold 0.15 M 
glycine and resuspended to a final concentration of 120 ×  106/ml for injection. Viability of the 
cells at the time of injection was -->96%. 
Generation ofCytotoxic  Lymphocytes In  Vitro.  Aliquots of 1-2 ×  107 TDL were washed twice 
and placed in plastic tissue culture flasks (Corning Glass Works, Science Products Div., Corning, 
N.Y.) in 20 ml of medium and stimulated with 2 ×  107 irradiated (1,200 rad) B10.BR, B10.K, 
or third-party H-2-different spleen cells. Cultures were incubated for 6 d at 37°C in 8% CO2. 
Cells were then harvested, washed twice, counted, and resuspended to appropriate concentra- 
tions for assaying cell-mediated lympholysis (CML). 
Target Cells  for CML.  To prepare target cells, 4 ×  106 lymph node cells were stimulated for 
2-3 d with 2 ~tg/ml of concanavalin A (Calbiochem-Behring Corp., American Hoechst Corp., 
San Diego, Calif.)  in 2-ml Linbro plates (Linbro Chemical Co., Hamden, Conn.). Blasts were 
labeled during the final 18 h with 20 ~Ci of 51Cr-sodium  chromate (New  England Nuclear, 
Boston, Mass.).  After labeling, the cells were washed three times and resuspended to 2 ×  105/ 
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CML Assay.  In a modification of the method of Brunner et al. (20), 100 ~1 of serially diluted 
effector cells together with  104 5aCr-labeled  target cells in 50 #1 were placed in triplicate in V- 
bottom microtiter plates (Linbro Chemical Co.), centrifuged gently (400 rpm for 4 min), and 
then incubated for 5 h at 37°C. After centrifugation,  100/LI of the supernates were removed to 
measure radioactivity in an Intertechnique y-spectrometer. Maximum release  of radioactivity 
(MR) and spontaneous release  (SR) were determined with respect to radioactive counts released 
after incubation with centrimide-saline and medium, respectively; SR ranged from 15 to 35% 
of MR. The percent specific lysis was calculated by the formula: (experimental release  -  SR/ 
MR -  SR) X  100; CML obtained on the syngenic CBA targets was invariably <7%. 
Calculation of Lytic Units of CML Activity.  To compare the relative  levels  of CML in  the 
experimental groups vs. the control group, lytic units (LU) of CML activity were calculated by 
a modification of the method of Cerottini  and Brunner (21).  LU were defined arbitrarily in 
terms of the number of effector cells  required  to exert  25% CML  (LU 25%). LU 25% were 
calculated from dose-response linear regression  lines plotted with respect to CML observed with 
three different killer:target  ratios; correlation coefficients for linearity were generally >0.95. 
The lytic activity of each experimental group of effector cells compared with the control group 
was calculated by the formula: (LU 25% control/LU 25% experimental)  X  100. 
Results 
Experimental Design.  The basic aim was to examine the requirements  for inducing 
CBA(H-2  k) T  cells to exert cytotoxic responses against the multiple minor HA on H- 
2-compatible B 10.BR target cells (CBA and B 10.BR differ at a minimum of six minor 
HA loci [22]). To study selection to these antigens, CBA mice were injected intrave- 
nously with large doses of spleen cells tape from mice of the B 10 congenic lines, e.g., 
B10.BR, B10(H-2b), or B10.D2(H-2d);  these strains  all express  the same minor HA 
foreign to CBA but have differing H-2 haplotypes. TDL, spleen, or lymph node cells 
were harvested  from the  recipients  at  day  1  (negative  selection)  or day 5  (positive 
selection)  posttransfer  and cultured  in vitro for 6  d  with H-2-compatible B 10.BR or 
B 10.K stimulator cells; these stimulators were used irrespective of the H-2 haplotype 
of the cells used to produce selection. CML  (~lCr release) was then tested on a variety 
of target cells. 
Preliminary  studies  established  that  the  effector  cells  in  the  CBA  anti-B10.BR 
CML  responses  were T  (Thy-l.2-positive)  cells  (data  not  shown).  Because  primary 
CML responses to minor HA in vitro are very low, the CBA TDL donors were primed 
with  B10.BR spleen cells 3-6 wk before inducing selection.  At this  time, TDL  from 
the primed  donors were not directly cytotoxic even at  high  (300:1)  killer:target  cell 
ratios  (data  not  shown)  and  hence were probably typical circulating  memory cells. 
To facilitate comparison of levels of cytotoxic activity, the data in most of the tables 
are shown first  in  terms  of specific 51Cr release observed with  different  killer:target 
cell  ratios,  and  second  as  the  percent  lytic  activity  established  with  respect  to  the 
control cells, i.e., cells from CBA mice preinjected  with syngeneic spleen cells  (Mate- 
rials and Methods). 
Specificity of the CML Response of CBA T Cells Cultured with BIO.BR Stimulators: Genetic 
Mapping  Studies.  Before studying selection  it  was  first  necessary  to  prove  that  the 
CBA anti-B10.BR CML response was indeed H-2 restricted,  i.e., as reported for other 
anti-minor HA responses  (3, 4). 
The cytolytic activity of unselected CBA TDL  (TDL from recipients  of syngeneic 
spleen  cells)  cultured  in  vitro  with  B10.BR  stimulators  is  shown  in  the  left-hand 
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TABLE  I 
Genetic Mapping of CML Activity of CBA  TDL Stimulated In  Vitro with B I O.BR Spleen: Effect of 
Negatively Selecting Responder Cells Against  Qa-l" Determinants on (BALB/c  ×  A/J)FI  (CAFl) 
Spleen Cells 
SlCr-labeled target  H-2 haplotype  Qa-I 
cells  allele* 
CML activity of CBA 
TDL cultured in vitro 
with BI0.BR spleen:~ 
Percent specific lysis 
with killer:target cell 
ratios of 25:1/12:1/2:1 
K  I-A  I-B  I-J  I-E  I-C  S  D  CBA-csA  CBA-cAF~ 
TDL  TDL 
CBA  k  k  k  k  k  k  k  k  b  6/5/0  0/0/0 
B10.BR  k  k  k  k  k  k  k  k  a  80/81/57  64/57/28 
BI0.K  k  k  k  k  k  k  k  k  b  58/50/24  41/38/18 
B 10  b  b  b  b  b  b  b  b  b  7/0/0  0/0/0 
B10.D2  d  d  d  d  d  d  d  d  b  0/0/0  0/0/0 
B10.Q  q  q  q  q  q  q  q  q  ?  0/0/0  0/0/0 
B10.A  k  k  k  k  k  d  d  d  a  69/57/20  44/33/12 
BI0.OL  d  d  d  d  d  d  k  k  )  36/38/14  36/34/12 
B10.A(4R)  k  k  b  b  b  b  b  b  b  30/31/4  38/22/8 
B 10.T(6R)  q  q  q  q  q  q  q  d  a  56/43/16  9/6/0 
B10.SOR  )  s  s  s  k  k  d  d  d  a  49/51/19  9/0/0 
B 10.HTT  s  s  s  s  k  k  k  d  b  0/0/0  0/0/0 
B 104.AQR§  q  k  k  k  k  d  d  d  a  40/31/0  0/0/0 
* Information from Klein et al.  (23) and L. Flaherty (Personal  communication.). Although there is some 
uncertainty in the literature on the identity of the T region-linked antigens that evoke H-2-unrestricted 
CML (24-28),  the prevailing opinion at present is that the determinants are probably encoded by genes 
closely linked to the Qa-1 locus adjacent to the Tla locus (L. Flaherty. Personal  communication.). 
:~ TDL from CBA mice injected intravenously 1 d before with  1 ×  10  a irradiated CBA spleen  (CBA-cBA 
TDL) or (BALB/c ×  A/J)F1 (Qa-I  b X  Qa-la) spleen (CBA-cAF, TDL). TDL donors  primed 4 wk before 
with B10.BR spleen. 
§ Although  these  mice were only of the  fourth  backcross  generation,  they  contain  >94%  of the  B10 
background genome. 
(B10.BR)  and the closely related strain,  B10.K,  but was not detectable with three H- 
2-different target cells that expressed the minor HA of BI0.BR, i.e., B10, B10.D2, and 
B IO.Q(H-2q).  Although these data implied that CML  was H-2 restricted, good killing 
was surprisingly observed with B 10.T(6R)  (qqqqqqqd)  targets, i.e., cells lacking the H- 
2 h  alleles  of the  CBA  responders.  Moreover,  CML  was  also  apparent  against  two 
strains  possessing  H-2 k  alleles  only  in  the  I  region,  i.e.,  B10.S(9R)  (ssskkddd)  and 
B104.AQR  (qkkkkddd)  (Table I, footnote).  It is evident  from Table  I  that  these three 
strains,  together  with  the  stimulating  population  B10.BR,  all  differ with  respect  to 
the  responder  cells  at  the  Qa-1  locus:  CBA  mice  are  Qa-1 b,  whereas  the  other  four 
strains are Qa-l". On this point several groups have shown that determinants  encoded 
by genes mapping  to the right of the H-2 complex in or near the Qa-1 locus (Table I, 
footnote)  lead  to  high  cytotoxic responses  that  do  not  show  H-2  restriction  (24-28). 
The effect of depleting CBA T  cells of reactivity to Qa-1 a determinants  is shown in 
the right-hand  column of Table I. To induce negative selection to these determinants, 
TDL  were collected from CBA mice that  had  been injected  1 d  previously xOith large 
doses  (108)  of irradiated  (BALB/c  ×  A/J)F1  spleen  cells,  i.e.,  cells  that  express  the 
foreign Qa-1 a determinants  of B 10.BR  but  lacking the  majority of the  minor  HA  of 318  NEGATIVE SELECTION TO  MINOR  H  DETERMINANTS 
TAm.E  II 
Negative  and Positive Selection of CBA Response to B I O. BR Minor H  Determinants:  CML-Precursor 
Reactivity  of Lymphoid  Cells from CBA Mice Injected with Irradiated  BIO.BR Spleen cells I or 5 d 
Before 
CML activity of CBA 
lymphoid cells cultured in 
vitro with BI0.K stimulators 
Irradiated spleen  CBA lymphoid cells tested 
cells given to  Dose of spleen cells  Percent specific  Percent 
donors of CBA  injected*  (time after spleen cell injec- 
lymphoid cells  tion)  lysiStargetsOn  B10.BRwith  lytiCtivityaC- 
killer:target  compared 
cell ratios of  with con- 
30:1/15:1/3:1  trol cells:~ 
CBA  2 ×  108  TDL (day  1)  62/55/17  -- 
B10.BR  2 ×  108  TDL (day  1)  19/0/0  2§ 
BI0.BR  1 ×  10  s  TDL (day  1  0/0/0  <1§ 
B10.BR  0.5 ×  10  s  TDL (day  1)  65/58/19  111 
CBA  2 ×  10  s  spleen  (day  1)  60/39/8  -- 
BI0.BR  2 X  l0  s  spleen  (day  1)  81/65/23  212 
CBA  2 X 10  s  lymph node (day  1)  86/72/46  -- 
B10.BR  2 X 108  lymph node (day  1)  80/73/42  84 
CBA  2 x  10  s  TDL (day 5)  84/69/34  -- 
BI0.BR  2 ×  l0  s  TDL (day 5)  87/85/49  288 
* Spleen cells exposed to 2,000 rad and then cultured for 4 h in vitro before injection; dose refers to number 
of viable cells injected. 
:~ CML activity of cells from mice injected with B 10.BR spleen compared with control mice given syngeneic 
spleen  (Materials and Methods). 
§ Culture of these cells with third-party (BALB/c ×  B6)FI (H-2 a X  H-2 h) stimulators led to high CML 
against  B 10 (H-2 b) and B lO.D2(H-2 a) target cells, i.e., >40% lysis at killer:target cell ratios of 15:1. 
this  strain.  It  is evident  that  this  procedure  virtually  abolished  the  anomalous  lysis 
against B10.T(6R), B 10.S(9R)  and B 104.AQR target cells but only marginally affected 
lysis of other targets.  However,  the  point  to  be emphasized  is that  the specificity of 
CML  was  now  in  accord  with  the  results  of other  workers  (3,  4),  i.e.,  CML  to  the 
minor HA of the stimulator  strain  was restricted  to target  cells that  were compatible 
with the responder strain at either the K- or D-end of the H-2 complex. There was no 
lysis of target cells that  were H-2 compatible only in the I  region. 
The  data  in Table  I  imply that  CML  to Qa-1 a determinants  would  be avoided  if 
B10.K  (Qa-l~  cells  rather  than  B10.BR  cells  were  used  as  stimulators.  This  was 
indeed  the case,  i.e.,  in  other experiments  (data  not  shown),  the  CML  specificity of 
CBA TDL  stimulated  with  B 10.K cells was  virtually identical  to  that  seen  in Table 
I with CBA-c^v, TDL  cultured with B10.BR cells. Hence to prevent the complication 
of generating  anti-Qa-1 a  activity,  2  most  of the  experiments  to  be  considered  below 
employed  B10.K  cells  as  stimulators  and/or  target  cells.  B10.K  mice  were  in  short 
supply  and  hence could not be used in all experiments.  All of the experiments  in the 
tables below were repeated  at  least once and  normally  2-3  times. 
Negative Selection  to Minor HA  Induced with  Irradiated H-2-Compatible  Spleen  Cells.  To 
induce  selection, CBA  mice were  injected  intravenously  with  large  doses  of CBA  or 
2 It is worth mentioning that the anti-Q  a- 1 CML apparent in Table I tended to be variable in magnitude 
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TABLE  III 
Negative  Selection of CBA Response to B I O. BR Minor H  Determinants 
Induced by Injection of lrradiated  B I O.BR, B I O, or B I O.D2 Spleen  Cells 
CML activity ofCBA TDL cultured in 
vitro with B 10.BR or SJL stimulators 
Irradiated 
spleen cells 
(2 X  l0  s)  H-2 haplotype 
given to  of injected 
donors of CBA  spleen cells 
TDL  1 d 
before* 
Stimulation with BI0.BR  Stimulation 
with SJL 
Percent 
Percent spe-  lytic  Percent specific 
cific lysis on  activity  lysis on SJL 
BIO.BR 
targets with  com-  target with 
pared  killer:target 
killer:target  with  cell ratios of 
cell ratios of  control  20:1/5:1/1:1:~ 
20:1/5:1/1:1~:  cells§ 
CBA  H-2 ~  52/33/5  --  NDll 
B 10.BR  11-2 ~  4/0/0  < 1  58/38/9 
BI0  H-2 b  0/0/0¶  <1  67/36/14 
B 10.D2  H-2 a  2/0/0¶  < l  63/40/13 
* Spleen cells were irradiated and cultured in vitro before injection as in Table 
II. 
In other experiments, CML tested on B10.K target cells gave similar results. 
§ See Table II. 
[1 Not done. 
¶ According to the data presented in Table I, selection against B10 or B10.D2 
cells (both Qa-I o) should have led to only a partial reduction in the response 
to B 10.BR targets, the residual activity being directed to Qa-1" determinants. 
The fact that there was near-total unresponsiveness towards B 10.BR targets 
in  the experiments illustrated  (and also  in one other experiment)  is  thus 
surprising.  However,  it  should  be  mentioned  that  in  other  experiments 
injection of BI0.D2 cells did lead to the expected incomplete reduction in 
the response to BI0.BR  (Qa-I")  targets but  complete unresponsiveness to 
B10.K  (Qa-I b)  targets. We attribute this variability in the degree of unre- 
sponsiveness to B10.BR targets to the fact that, at times, anti-Q.a-1  killing 
forms only a minor component of the CBA/J anti-B 10.BR response. 2 It is to 
be emphasized that in all three experiments in which B10.K targets were 
used to monitor selection (data not shown), prior injection of CBA/J mice 
with B 10.BR, B 10, or B 10.D2 cells all led to almost total unresponsiveness to 
BI0.K targets (<1% lyric activity). 
B10.BR  spleen  cells;  these  cells  were  heavily  irradiated  before  injection  to  prevent 
recirculation  and  entry  into  the central  lymph  (16).  Lymphoid  cells  were  harvested 
from the recipients  1 or 5  d  later, stimulated  in vitro with B 10.K cells, and then tested 
for their capacity  to exert CML  against  B 10.BR  targets  (Experimental  Design). 
The  results of a  typical experiment  are shown  in Table  II.  It can be seen that TDL 
from  CBA  mice  given  B10.BR  spleen  cells  in  large  doses  1  d  before  were  unable  to 
generate CML  against  B10.BR  targets.  Selection  was  specific  because stimulation  of 
the  TDL  with  third-party  H-2-different  cells  gave  high  levels  of  lysis  (Table  II, 
footnote; and later tables). The extent of selection against B 10.BR was dose dependent: 
2  ×  l0  s and  l0  s cells usually caused near-complete  unresponsiveness, whereas selection 
was minimal  with smaller cell doses. 
In contrast  to the unresponsiveness of TDL,  spleen cells taken at  1 d  after B10.BR 
spleen  cell  injection contained  normal  or enriched  numbers  of B10.BR-reactive  cells 320  NEGATIVE  SELECTION TO  MINOR  H  DETERMINANTS 
TABLE  IV 
Negative and Positive Selection of CBA Response to B I O.BR Minor H Determinants Induced by Injection of 
Sonicated BIO.BR, BIO, or BIO.D2 Spleen Cells 
Sonicates of spleen 
cells (2 ×  l0  s) given 
to donors of CBA 
lymphoid cells* 
CBA lymphoid cells tested 
(time after spleen cell 
injection) 
CML activity ofCBA TDL cultured in vitro with 
B10.BR or SJL stimulators 
Stimulation with BIO.BR  Stimulation with 
SJL 
Percent specific  Percent  Percent specific 
lysis on B 10.BR  lyric activ-  lysis on SJL 
targets with  ity corn-  targets with 
killer:target  pared with  killer:target 
cell ratios of  control  cell ratios of 
25:1/12:1/2: l  cells:~  25:1/12:1/2:1 
CBA  TDL  (day 1)  78/74/46  --  ND§ 
B10.BR  TDL  (day 1)  7/9/0  <1  68/56/12 
BI0  TDL  (day 1)  19/10/4  <1  68/52/10 
B10.D2  TDL  (day 1)  0/0/0  <1  58/58/10 
CBA  spleen  (day 1)  78/65/42  --  ND 
BI0.BR  spleen  (day 1)  86/67/48  140  ND 
B10  spleen  (day 1)  61/48/26  32  ND 
B10.D2  spleen  (day 1)  70/70/33  58  ND 
B10.BR  TDL  (day 5)  74/61/37  42  ND 
* See  Materials  and  Methods  for preparation of sonicates; sonicates given  intravenously.  To  remove 
reactivity to Qa-1 ~ determinants,  the CBA lymphoid  donors were also injected with  irradiated CAFj 
spleen cells, i.e., as in Table I. 
~: See Table II. 
§ Not done. 
(Table II). With lymph node cells the response was either unchanged or moderately 
reduced.  When TDL  were harvested at  5  d  posttransfer rather than  at  day  1,  anti- 
B 10.BR responses were usually enhanced. 
Collectively, these data imply that, as with other antigens, T  cells that  encounter 
minor HA in vivo rapidly become sequestered in the lymphoid tissues, particularly in 
the spleen, and then  reenter the circulation several days later after clonal expansion. 
Negative Selection with Irradiated H-2-Incompatible Spleen Cells.  Further studies showed 
that  the H-2 haplotype of the minor HA-bearing spleen cells given to the donors of 
CBA TDL  had no  apparent  effect on  the degree of selection to B10.BR  minor HA 
determinants.  Thus,  irrespective of whether the injected spleen cells were  H-2  com- 
patible (B10.BR)  or H-2 different  (B10 or B10.D2)  with respect to the responding T 
cells, reactivity to B10.BR  targets (Table III) or B 10.K targets (data not shown)  was 
virtually undetectable; again, responsiveness to third-party antigens was unimpaired 
(Table III). 
Negative  Selection  with  Disrupted Spleen  Cells.  Because  heavily  irradiated  cells die 
within a  few hours of injection (29), the above data raised the possibility that antigen 
selection was  initiated not  by  intact  cells but  by  cell  fragments.  According to  this 
possibility, disrupting  the  spleen  cells before  injection  would  not  impair selection. 
Indeed, as shown  in Table IV the injection of extensively sonicated B10.BR,  B10, or 
B10.D2  spleen cells all led,  1 d  later, to complete unresponsiveness of TDL  against 
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TABLE V 
Negative Selection of CBA Responses to B IO.K Minor H Determinants 
Induced by Injection of Glutaraldehyde-treated Spleen Cells: Selection Induced 
with BIO.BR Spleen but not with BIO, BIO.D2, or BIO. Q Spleen 
Glutaralde- 
hyde-treated 
spleen cells (1.2 
×  l0  s) given to 
donors of CBA 
TDL 1 d be- 
fore* 
CML activity ofCBA TDL cultured in vitro with 
BI0.BR or (BALB/c X B6)F1 stimulators 
Stimulation with 
B10.BR 
Stimulation with (BALB/c × 
B6)F1 (H-2  d × H-2 b) 
Percent  Percent spe-  Percent spe- 
Percent spe-  lytic ac-  cific lysis on 
cific lysis on  cific lysis on  BIO.D2(H_2  a) 
B 10.K targets  tivity  B 10(H-2  b) 
targets with  with killer:tar-  corn-  targets with  killer:target 
get cell ratios  pared  killer:target  with  cell 
of 20:1/10:1/  control  cell ratios of  ratios of 
2:1  20:1/10:1/2:1  cells:~  20:1/10:1/2:1 
CBA  74/72/34  --  ND§  ND 
BI0.BR  10/5/0  <1  71/57/21  83/64/27 
B 10  67/62/31  84  ND  ND 
B10.D2  58/52/22  49  67/56/16  6/3/0 
B10.Q  77/63/39  127  ND  ND 
* See Materials and Methods for glutaraldehyde treatment. 
:~ See Table II. 
§ Not done. 
after  injection  of sonicated  cells  gave  high  responses  and  the  reactivity  of TDL 
returned toward normal levels by day 5 posttransfer. 
Negative Selection  with Glutaraldehyde-treated  Spleen Cells.  The simplest interpretation 
of the  above  data  is  that,  at  least  in  H-2-incompatible situations,  T-cell  selection 
depended  upon  the minor HA on  the injected spleen cells being processed in some 
way by host  cells, e.g.,  by macrophages  or related cells. If so,  mild  fixation  of the 
injected spleen cells might impair antigen processing and thereby block selection. To 
examine this point the injected spleen cells were treated lightly with glutaraldehyde 
(0.002%  for 30 s  [Materials and Methods]).  This treatment  had no immediate effect 
on cell viability as assessed by dye exclusion, and mCr-labeling studies indicated that 
the cells homed normally to the spleen after intravenous injection (data not shown). 
The effects of glutaraldehyde-treating the selecting cells is shown  in Table V.  In 
the case of injecting H-2-compatible B 10.BR  cells, negative selection was as marked 
with glutaraldehyde-treated cells as with intact irradiated cells (compare with Table 
II).  With  H-2-different  B10,  BI0.D2,  or  B10.Q  cells,  by  contrast,  glutaraldehyde 
treatment almost completely abolished selection, i.e., TDL from mice preinjected with 
these cells generated near-normal levels of CML  against either B10.K targets (Table 
V) or B10.BR targets (data not shown). 
Although H-2-different glutaraldehyde-treated cells failed to induce negative selec- 
tion to minor HA, injection of these cells did lead to effective selection against the H- 
2  determinants  on  the  cells.  For  example,  when  CBA  TDL  from  recipients  of 
glutaraldehyde-treated B lO.D2(H-2 u) cells were stimulated in vitro with  (BALB/c × 
B6)Fx(H-2 a  ×  H-2~  ceils, CML  was  low or absent  against BI0.D2  targets but  was 
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TABLE VI 
Negative Selection to Minor H  Determinants Induced by Injecting CBA Mice with Glutaraldehyde- 
treated Spleen Cells from Mice of the B IO Recombinant Strains 
CML activity ofCBA TDL cultured  in vitro with BI0.K stimula- 
tors. Killer:target cell ratios of 25:1/12:1/2:1 
Glut araldehyde-treated 
spleen cells (1.2 x  10  a)  Percent  Percent  Percent 
given to donors of CBA  specific  Percent  specific  Percent  specific  Percent 
TDL l d before*  lysis on  lytic ac-  lysis on  lytic ac-  lysis on  lyric ac- 
B10.K tar-  tivity  B10.A  tar-  tivity  B10.OL  tivity 
gets  gets  targets 
CBA (kkkkkkkk)  49/41/22  49/42/17  --  34/28/13  -- 
B 10.OL (ddddddkk)  31/27/7  22  41/28/9  46  8/3/0  <l 
B 10.A (kkkkkddd)  0/0/0  < 1  0/0/0  < 1  0/0/0  < 1 
(BI0.A X B10.OL)F~  9/1/0  <1  9/7/0  <1  0/0/0  <I 
B 104.AQR (qkkkkddd)  0/0/0  < 1  0/0/0  < 1  0/0/0  < 1 
* See Table V. 
Negative  Selection  with  Glutaraldehyde-treated  Cells from  H-2  Recombinant  Mice.  To 
attempt  to map  the apparent  H-2  restriction of selection observed with  glutaralde- 
hyde-treated cells, selection was  studied in CBA  mice given  glutaraldehyde-treated 
cells from  mice of the B10  recombinant strains. When  B10.OL  (ddddddkk)  cells were 
used for selection, culture of the recipient CBA TDL  with  B10.K stimulators led to 
effective lysis against B10.A (kkkkkddd)  targets but not against B10.OL targets (Table 
VI).  These  data  implied  that  selection  affected  T  cells  specific  for  determinants 
mapping in the D-end of the H-2 complex but did not involve K-end-specific T  cells. 
Reciprocal findings were expected when B 10.A cells were used for selection. Curiously, 
however, this was not the case: Selection with B 10.A cells led to unresponsiveness not 
only against B 10.A targets but also against B I0.OL targets, i.e., as for selection with 
(B10.A  ×  B10.OL)F1  cells.  Identical  findings  applied  to  selection  with  B104.AQR 
(qkkkkddd)  cells, i.e., cells that were H-2 compatible with the host only in the I region. 
Three other experiments gave comparable findings. In two of these experiments, as a 
specificity control, the cells selected against B 10.A and B 104.AQR cells were tested for 
their capacity to generate CML  against third-party H-2 b target cells. High levels of 
lysis were obtained (data not shown). 
Discussion 
Most of the evidence on cross-priming to minor HA has come from studies on the 
long-term  effects  of  immunizing  mice  with  H-2-different  cells.  Our  findings  that 
negative selection  to  minor  HA  can  be  induced  with  irradiated or  disrupted  H-2- 
different cells implies that  cross-priming can occur very rapidly, i.e., within  1 d.  As 
with other examples of cross-priming, these data per se might either reflect processing 
of antigen by host cells (thus enabling the antigen to become associated with self H- 
2  determinants)  or  alternatively  signify  a  lack  of  H-2  restriction  during  T-cell 
induction.  The  experiments  on  the effects of using  glutaraldehyde-treated cells for 
selection were designed to discriminate between these two possibilities. 
The  rationale  here  was  that  if cross-priming  resulted  from  antigen  processing, 
treatment  of the antigen-bearing cells with  a  fixative such  as glutaraldehyde might 
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selection  across  H-2  barriers.  Indeed,  testing  this  prediction  showed  that  negative 
selection to minor HA induced by H-2-different cells was low or undetectable when 
the  cells  were  treated  briefly  with  low  concentrations  of  glutaraldehyde  before 
injection.  Significantly,  glutaraldehyde  treatment  did  not  affect  selection  in  H-2- 
compatible situations,  i.e.,  in contrast to irradiated  or sonicated cells,  selection with 
glutaraldehyde-treated cells was H-2 restricted. 
In interpreting these data it should first  be stressed that the precise mechanism of 
action  of  glutaraldehyde  treatment  in  the  selection  assay  is  unknown.  Because 
glutaraldehyde cross-links proteins (30), our working hypothesis is that treatment with 
this  reagent  retards  destruction  of the  antigen-bearing cells  and/or  interferes  with 
antigen processing by host cells, e.g., by somehow preventing moieties of antigen from 
forming an  immunogenic association with  host  H-2 determinants.  Although this  is 
largely speculation it is difficult to offer an alternative explanation that fits the data. 
The fact that glutaraldehyde-treated cells remained immunogenic in H-2-compatible 
situations  makes it  unlikely that  the antigenicity of the  minor HA on the selecting 
cells  was  impaired.  Likewise,  the  H-2  determinants  on  the  cells  seemed  to  remain 
intact  because  effective  selection  was  observed  against  the  H-2  determinants  on 
glutaraldehyde-treated cells  (Table V). Indeed there appears to be general agreement 
in  the literature  that  glutaraldehyde treatment  does not denature cell  surface com- 
ponents (19, 31, 32), at least under the mild conditions used in this study. It may also 
be mentioned that in our hands glutaraldehyde treatment does not prevent long-term 
cross-priming,  i.e.,  CBA  mice  injected  several  weeks  before  with  glutaraldehyde- 
treated  B10.D2 spleen  cells  give typical secondary responses  to B10.K cells  in  vitro 
(R. Korngold and J. Sprent. Unpublished data.). 
Whatever the exact consequences of treating cells with glutaraldehyde, the fact that 
selection to minor HA was H-2 restricted would seem to exclude the possibility that 
selection reflected an H-2-unrestricted response to antigen. 3 Can one conclude there- 
fore that cytotoxic T-cell induction depends upon some form of antigen processing? 
In the case of cross-priming (presentation of antigen on H-2-different cells),  the data 
on the  immunogenicity of irradiated  and disrupted  cells  vs.  glutaraldehyde-treated 
cells  in  the  selection  assay  are  strongly  in  favor  of this  viewpoint.  The  precise 
mechanism  of  induction  to  minor  HA,  however,  is  far  from  clear.  Because  the 
specificity of the effector cells was directed to K- and D-end H-2 determinants (Table 
I),  it  is  tempting  to  extrapolate  from  the  induction  of I  region-restricted  T  cells 
involved in T-B collaboration and argue that cytotoxic precursor cells  are triggered 
by contact with antigen that becomes associated with K/D determinants on macro- 
phages or related cells.  Although appealing from the point of view of symmetry, this 
notion has to be viewed with caution for the following reasons: (a) The recent evidence 
that I region-restricted T-helper cells  control responses to minor HA (33-36)  adds a 
new  dimension  to  the  problem  of cytotoxic T-cell  induction  and  implies  that,  in 
addition to K/D determinants, the antigen-presenting cells might also have to express 
Ia determinants.  (b) There is no direct evidence that macrophages or accessory cells 
play other than a  nonspecific role in cytotoxic T-cell induction in vitro  (37).  For in 
Although primed mice were used in these experiments, recent studies in which unprimed T cells were 
primed to antigen on adoptive transfer after selection to glutaraldehyde-treated cells have given similar 
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vivo responses, the only direct evidence that a specific class of antigen-presenting cells 
is  required  for CML  induction  is  the  finding  of Zinkernagel  et  al.  (38)  that  H-2- 
compatible cells  of bone  marrow origin  are  needed  for generating  CML  to  virus- 
infected cells; whether these cells belong to the macrophage lineage is unknown.  (c) If 
typical macrophages do control antigen presentation, it remains to be explained why 
cross-priming is easily demonstrable in vivo but  not  in vitro (12).  For these reasons 
the  case  that  cytotoxic  T-cell  induction  is  simply  a  reflection  of T-macrophage 
interaction and closely resembles the induction of T  cells involved in T-B collabora- 
tion is far from being proved. 
The conclusion that antigen processing is a  prerequisite for inducing responses to 
minor HA across H-2 barriers does not necessarily imply that processing is mandatory 
in  H-2-compatible situations.  Indeed  the  argument  that  glutaraldehyde  treatment 
impairs antigen  processing rests on the assumption  that  the selection to minor HA 
observed with H-2-compatible glutaraldehyde-treated  cells reflects a  response to the 
injected cells per se.  This latter finding was predictable because virtually all of the 
injected  spleen  cells presumably expressed the  requisite  combination  of minor HA 
plus self K/D determinants. Nevertheless it is conceivable that, even in this situation, 
the capacity to present antigen  is unique to a  particular class of cells. This question 
is currently under investigation. 
Finally, comment should be made on the paradoxical effects of inducing selection 
with glutaraldehyde-treated cells from mice of the B 10 recombinant strains. Because 
there  is  general  agreement  that  H-2K-  and  H-2D-restricted  CML  is  mediated  by 
distinct  subgroups  of T  cells,  the  expectation  was  that  these  subgroups  could  be 
separated by inducing selection with minor HA-bearing cells that  were compatible 
with the host at only one end of the H-2 complex. The results of selecting CBA(H-2  k) 
mice against glutaraldehyde-treated B 10.OL (ddddddkk) cells were consistent with this 
prediction,  i.e., selection with these cells abolished CML to B10.OL target cells but 
only minimally impaired the response to B 10.A (kkkkkddd) targets. Reciprocal selection 
with B 10.A cells, by contrast, led to unresponsiveness against both B 10.A and B 10.OL 
targets. In interpreting these data it may be relevant that in the case of B10.A cells, 
the cells used for selection shared Ia antigens with the host. Hence, negative selection 
with B 10.A cells might remove not only K-end-restricted cytotoxic precursors but also 
I  region-restricted T-helper cells critical for facilitating differentiation in vitro of the 
unsetected D-end-restricted cells (36). Accordingly, selection with cells that were H-2 
compatible with  the host  only in  the  I  region would  be expected to have a  similar 
effect.  This  was  indeed  found  to  be  the  case,  i.e.,  selection  of CBA  mice  with 
glutaraldehyde-treated  B104.AQR  (qkkkkddd) cells  led  to  marked  unresponsiveness 
against both B10.A and B10.OL targets (Table VI). 
Which particular H-2Isubregion(s) must be matched to obtain selection is currently 
under  investigation.  Preliminary studies  have shown  unexpectedly that  selection of 
the CBA anti-B10.K response can be induced with either B10.A(4R)  (kkbbbbbb) cells 
or B10.HTT (sssskkkd) cells, i.e., cells that are H-2I compatible with the host only at 
the I-A and I-E/C subregions, respectively. Such  findings are not easily interpreted. 
Proving the participation of I region-restricted T-helper ceils in this system, however, 
will require demonstrating that addition of these cells in culture can reconstitute the 
cytotoxic  activity  of the  supposedly  T-helper  cell-deficient  selected  T  cells.  Such 
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Summary 
Intravenous injection of CBA mice with H-2-compatible irradiated  B10.BR spleen 
cells  led to a  sequence of negative  and  positive selection  of the host T-cell  response 
against  the multiple  foreign minor histocompatibility antigens  (HA)  on the injected 
cells.  By  1 d  posttransfer,  thoracic duct  lymphocytes (TDL)  of the host had lost  the 
capacity  to differentiate  in  vitro  into  cytotoxic cells  specific  for the  injected  minor 
HA; spleen and lymph node cells, by contrast,  gave normal or enriched responses at 
this  time.  By 5  d  posttransfer,  TDL  were hyperresponsive  to the  injected  antigens. 
Selection with disrupted  (sonicated)  cells gave similar findings. 
With  injection of either irradiated  or disrupted  spleen  cells,  the H-2 haplotype of 
the minor HA-bearing cells had no apparent effect on the magnitude of selection. By 
contrast,  treatment  of spleen  cells  with  glutaraldehyde  before  injection  led  to  H-2 
restriction  of selection,  i.e.,  negative  selection  of the  CBA response  to  B10.BR  was 
marked  with  injection  of glutaraldehyde-treated  H-2-compatible  B10.BR  cells  but 
was minimal with H-2-different  B10 or B 10.D2 cells.  These data are taken  to imply 
that,  at  least  in  H-2-incompatible  situations,  the  minor  HA-bearing  cells  must  be 
processed by host cells, i.e., to allow the antigens to become associated with self H-2 
determinants. 
Circumstantial  evidence  from studies  on the specificity of selection  induced with 
glutaraldehyde-treated  cells from mice of the B 10 recombinant strains suggested that 
I  region-restricted T  cells may control the induction of H-2K, D-restricted cytotoxic 
precursor cells. 
The skillful typing assistance of Mrs. K. King and Mrs. T. McKearn is gratefully acknowledged. 
We are most grateful to Doctors David, Doherty, Elkins,  and Gasser for their gifts of various 
mouse strains, and to Doctors Elkins,  Gasser, McKearn, Silvers,  and Wettstein for reading the 
manuscript. 
Received  for publication 17 September 1979 and in revised  form 15 November 1979. 
References 
1.  Doherty, P. C., R. V. Blanden, and R. M. Zinkernagel.  1976. Specificity of virus-immune 
effector T  cells  for H-2K or H-2D compatible  interactions:  implications  for H-antigen 
diversity. Transplant. Rev. 29:89. 
2.  Shearer, G. M., T. G. Rehn, and A. M. Schmitt-Verhulst.  1976. Role of the murine major 
histocompatibility complex in the specificity of in vitro T cell mediated lympholysis against 
chemically-modified autologous lymphocytes. Transplant. Rev. 29;222. 
3.  Bevan,  M. J.  1975. The  major histocompatibility  complex determines  susceptibility  to 
cytotoxic T cells directed against minor histocompatibility antigens. J. Exp. Med. 142:1349. 
4.  Gordon,  R.  D.,  E.  Simpson, and  L.  E.  Samelson.  1975. In vitro cell-mediated  immune 
responses to the male specific (H-Y) antigen in mice.J. Exp. Med. 142;1108. 
5.  Snell,  G. D., N. Wheeler, and M. Aaron.  1957. A new method of typing inbred strains of 
mice for histocompatibility antigen.  Transplant. Bull. 4;18. 
6.  Gasser,  D. L., and W. K. Silvers.  1972. Genetics and immunology of sex-linked antigens. 
Adv. Immunol. 15:215. 
7.  Gordon, R. D., B. J. Mathieson, L. E. Samelson, E. A. Boyse, and E. Simpson.  1976. The 
effect  of allogeneic  presensitization  on  H-Y  graft  survival  and  in  vitro  cell-mediated 
responses to H-Y antigen.J.  Exp. Med. 144:810. 
8.  Wettstein,  P. T., G. Haughton, and J. A. Frelinger.  1977. Immune response to histocom- 326  NEGATIVE SELECTION  TO MINOR  H  DETERMINANTS 
patibility antigens: H-2 control of in vivo and in vitro effector:target interactions. In Immune 
System: Genetics and Regulation. E. E. Sercarz,  L. A. Herzenberg, and C. F. Fox, editors. 
Academic Press, Inc., New York. 623. 
9.  Murasko, D.  M.  1978. Apparent lack of H-2 restriction of allograft rejection. J.  Immunol. 
121:958. 
10.  Smith, F. I., and J. F. A. P. Miller. 1979. Delayed-type hypersensitivity to allogeneic cells 
in mice.  III. Sensitivity to  cell  surface antigens coded  by the  major histocompatibility 
complex and by other genes. J.  Exp. Med.  150:965. 
11.  Bevan, M. J.  1976. Cross-priming for a secondary cytotoxic response to minor H antigens 
with H-2 congenic cells which do not cross-react  in the cytotoxic assay. J.  Exp.  Med.  143: 
1283. 
12.  Matzinger, P., and M. T. Bevan. 1977. Induction of H-2 restricted cytotoxic T cells: in vivo 
induction has the appearance of being unrestricted. Cell, Immunol.  32:92. 
13.  Sprent, J., J. F. A. P. Miller, and G. F. Mitchell. 1971. Antigen-induced selective  recruit- 
ment of circulating lymphocytes. Cell, Imrnunol. 2:171. 
14.  Rowley, D.  A., J.  L.  Gowans, R.  C.  Atkins, W.  L.  Ford, and M.  E.  Smith.  1972. The 
specific  selection of recirculating lymphocytes by antigen in normal and preimmunized 
rats.J. Exp. Med.  136:499. 
15.  Ford, W. L., and R. C. Atkins. 1971. Specific unresponsiveness  of recirculating lymphocytes 
after exposure to histocompatibility antigens in F1 hybrid rats. Nat. New Biol.  243:178. 
16.  Sprent, J.,  and J.  F.  A.  P.  Miller.  1976. Effect  of recent  antigen priming on adoptive 
immune responses.  III. Antigen-induced selective  recruitment of subsets of recirculating 
lymphocytes reactive to H-2 determinants.  J.  Exp. Med.  143:585. 
17.  Sprent, J.  1978. Role of the H-2 complex in induction of T helper cells in vivo. I. Antigen- 
specific selection of donor T cells to sheep erythrocytes in irradiated mice dependent upon 
sharing of H-2 determinants between donor and host. J.  Exp.  Med.  148:478. 
18.  von Boehmer, H., and K. Shortman.  1973. The separation of different cell  classes  from 
lymphoid organs.  IX.  A  simple and rapid  method  for  removal of damaged cells  from 
lymphoid cell suspensions.  J.  Immunol.  2:293. 
19.  Bubbers, J.  E., and C.  S. Henney. 1975. Studies on the synthetic capacity and antigenic 
expression  of glutaraldehyde-fixed target cells. J. Immunol.  114:1126. 
20.  Brunner, K. T., J. Mauel, J. C. Cerottini, and B. Chapuis. 1968. Quantitative assay of the 
lyric action of immune lymphoid cells  on  51Cr-labelled  allogeneic target  cells  in  vitro: 
inhibition by isoantibody and by drugs. Immunology.  14:181. 
21.  Cerottini, J. C., and R. T. Brunner. 1974. Cell-mediated cytotoxicity, allograft rejection, 
and tumor immunity. Adv. Immunol.  18:67. 
22.  Korngold, R.,  and J.  Sprent.  1978. Lethal  graft-versus-host disease  after  bone marrow 
transplantation across minor histocompatibility barriers in mice.  Prevention by removing 
mature T cells from marrow.J. Exp.  Med.  148:1687. 
23.  Klein, J., L. Flaherty, J.  L. VandeBerg, and D. C. Shreffler.  1978. H-2 haplotype, genes, 
regions,  and antigens: first listing. Immunogenetics. 6:489. 
24.  Stanton, T. H., and E. A. Boyse. 1976. A new serologically defined locus, Qa-1 in the Tla- 
region of the mouse, hnmunogenetics. 3:525. 
25.  Klein, J.,  and C. Chiang.  1978. A new locus (H-2T) at  the D end of the H-2 complex. 
Irnmunogenetics. 6:235. 
26.  Forman, J., and L. Flaherty. 1978. Identification of a new CML target antigen controlled 
by a gene associated with the Qa-2 locus. Imrnunogenetics. 6:227. 
27.  Fisher Lindahl, K. 1979. Unrestricted killer cells recognize an antigen controlled by a gene 
linked to Tla. lrnrnunogenetics. 8:71. 
28.  Wernet, D., and J. Klein. 1979. Unrestricted cell-mediated lympholysis to antigens linked 
to the Tla locus in the mouse. Immunogenetics. 8:361. R.  KORNGOLD  ANDJ.  SPRENT  327 
29.  Anderson, R. E., and N. L. Warner.  1976.  Ionizing radiation and the immune response. 
Adv. Immunol. 24:215. 
30.  Avrameas, S., and T. Ternynck.  1969. The cross-linking of proteins with glutaraldehyde 
and its use for the preparation of immunoadsorbents. Immunochemistry. 6:53. 
31.  Frost, P., and C. V. Sanderson.  1975. Tumor immunoprophylaxis in mice using glutaral- 
dehyde-treated syngeneic tumor cells. Cancer Res. 35:2646. 
32.  Lightbody, J. J., and Y. M. Kong.  1976. Mitogen-stimulated glutaraldehyde-fixed spleen 
cells: ability to stimulate in the mixed lymphocyte reaction and generate effector cells in 
cell mediated lympholysis.  J. Immunol.  117:1336. 
33.  Simpson, E., and R. D. Gordon. 1977. Responsiveness to HY antigen. Ir gene complemen- 
tation and target cell specificity. Immunol. Rev. 35:59. 
34.  Gordon, R. D., and E. Simpson.  1977. Immune response gene control of cytotoxic T  cell 
responses to HY.  Transplant.  Proc. 9:885. 
35.  yon Boehmer,  H., W.  Haas, and  N.  K. Jerne.  1978. Major histocompatibility complex- 
linked immune-responsiveness is acquired by lymphocytes of low-responder mice differen- 
tiating in thymus of high-responder mice. Proc. Natl.  Acad. Sci. U. S. A. 75:2439. 
36.  yon Boehmer, H., and W. Haas.  1979. Distinct Ir genes for helper and T  killer cells in the 
cytotoxic response to H-Y antigen.J. Exp. Med.  150:1134. 
37.  Pettinelli, C. B., A. Schmitt-Verhulst, and G. M. Shearer. 1979. Cell types required for H- 
2-restricted cytotoxic responses generated by trinitrobenzene sulfonate-modified syngeneic 
cells or trinitrophenyl-conjugated proteins.J. Immunol.  122:847. 
38.  Zinkernagel, R. M., G. N. Callahan, A. Althage, S. Cooper, J. W. Streilein, and J. Klein. 
1978.  The  lymphoreticular system in  triggering virus plus self-specific cytotoxic T  cells. 
Evidence for T  help.J. Exp. Med.  147:897. 